Search Results - "Xiao, Tianhe"
-
1
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Published in Nature (London) (24-02-2022)“…The SARS-CoV-2 B.1.1.529 (Omicron) variant contains 15 mutations of the receptor-binding domain (RBD). How Omicron evades RBD-targeted neutralizing antibodies…”
Get full text
Journal Article -
2
Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
Published in Cell research (01-07-2021)“…SARS-CoV-2 variants could induce immune escape by mutations on the receptor-binding domain (RBD) and N-terminal domain (NTD). Here we report the humoral immune…”
Get full text
Journal Article -
3
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
Published in Nature (London) (18-08-2022)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sublineages BA.2.12.1, BA.4 and BA.5 exhibit higher transmissibility than the BA.2 lineage…”
Get full text
Journal Article -
4
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting
Published in Nature (London) (04-01-2024)“…The continuing emergence of SARS-CoV-2 variants highlights the need to update COVID-19 vaccine compositions. However, immune imprinting induced by vaccination…”
Get full text
Journal Article -
5
Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants
Published in Cell research (01-10-2021)Get full text
Journal Article -
6
CRISPR screening of porcine sgRNA library identifies host factors associated with Japanese encephalitis virus replication
Published in Nature communications (14-10-2020)“…Japanese encephalitis virus (JEV) is a mosquito-borne zoonotic flavivirus that causes encephalitis and reproductive disorders in mammalian species. However,…”
Get full text
Journal Article -
7
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Published in Nature (London) (23-12-2021)Get full text
Journal Article -
8
Omicron-specific ultra-potent SARS-CoV-2 neutralizing antibodies targeting the N1/N2 loop of Spike N-terminal domain
Published in Emerging microbes & infections (31-12-2024)“…A multitude of functional mutations continue to emerge on the N-terminal domain (NTD) of the spike protein in SARS-CoV-2 Omicron subvariants. Understanding the…”
Get full text
Journal Article -
9
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Published in Nature (London) (16-02-2023)“…Continuous evolution of Omicron has led to a rapid and simultaneous emergence of numerous variants that display growth advantages over BA.5 (ref. 1 ). Despite…”
Get full text
Journal Article -
10
Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75
Published in Cell host & microbe (09-11-2022)“…Recently emerged SARS-CoV-2 Omicron subvariant, BA.2.75, displayed a growth advantage over circulating BA.2.38, BA.2.76, and BA.5 in India. However, the…”
Get full text
Journal Article -
11
Antigenicity and infectivity characterisation of SARS-CoV-2 BA.2.86
Published in The Lancet infectious diseases (01-11-2023)“…By Sept 8, 2023, 95 sequences were detected, of which their early sequences originated from multiple countries, had no epidemiological relevance, and were…”
Get full text
Journal Article -
12
Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455-456 synergistically enhances antibody evasion and ACE2 binding
Published in PLoS pathogens (20-12-2023)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) XBB lineages have achieved dominance worldwide and keep on evolving. Convergent evolution of XBB…”
Get full text
Journal Article -
13
Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents
Published in Cell reports (Cambridge) (20-12-2022)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sublineages have escaped most receptor-binding domain (RBD)-targeting therapeutic…”
Get full text
Journal Article -
14
Isolation and characterization of a Sabin 3/Sabin 1 recombinant vaccine-derived poliovirus from a child with severe combined immunodeficiency
Published in Virus research (15-01-2022)“…•A long-term secreted Sabin 3/Sabin 1 recombinant vaccine-derived poliovirus from a child with severe combined immunodeficiency.•A modified NGS platform to…”
Get full text
Journal Article -
15
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1
Published in Nature (London) (07-11-2024)“…The continuous evolution of SARS-CoV-2, particularly the emergence of BA.2.86/JN.1 lineage replacing XBB, necessitates re-evaluation of vaccine compositions…”
Get full text
Journal Article -
16
Arming AAV9 with a Single-Chain Fragment Variable Antibody Against PD-1 for Systemic Glioblastoma Therapy
Published in Molecular neurobiology (14-08-2024)“…Glioblastoma (GBM) is a highly aggressive brain cancer with a low survival rate, prompting the exploration of novel therapeutic strategies. Immune checkpoint…”
Get full text
Journal Article -
17
Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity
Published in National science review (01-07-2024)“…Selective pressures have given rise to a number of SARS-CoV-2 variants during the prolonged course of the COVID-19 pandemic. Recently evolved variants differ…”
Get full text
Journal Article